Survey of pertussis morbidity in adults in western Sydney.
OBJECTIVE
To estimate morbidity due to Bordetella pertussis infection in a representative population of Australian adults.


METHODS
Telephone survey using structured questionnaire.


METHODS
Adults (aged 20 years and over) notified with pertussis to a public health unit in western Sydney between 1 December 1997 and 31 May 1998.


METHODS
Duration of cough; time to improvement; symptoms and complications; time to diagnosis; health resource use; lost work days.


RESULTS
Of 90 eligible patients, 73 (81%) completed questionnaires. Cough lasted a median of 60 days, but persisted over 90 days in 20 people (27%). Presentation was within a median of seven days of symptom onset, but diagnosis of pertussis took a median of 21 days. Participants reported a mean of 3.7 general practitioner visits and 1.2 prescription drugs. Of those employed, 17 (35%) missed more than five work days (range, 0-93 days).


CONCLUSIONS
B. pertussis infection in adults can result in prolonged, significant disruption to social and working life. Results suggest that, in 1998, there were more than 8000 general practitioner visits and 15,000 lost work days caused by pertussis in Australian adults.
Thomas
P F
PF
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), New Children's Hospital, NSW. paul.thomas@healthoz.com.au
McIntyre
P B
PB
Jalaludin
B B
BB
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006296:Health Services / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D009517:New South Wales / Q000453:epidemiology; D010567:Pertussis Vaccine / Q000627:therapeutic use; D018582:Sick Leave / Q000706:statistics & numerical data; D014917:Whooping Cough / Q000453:epidemiology* / Q000503:physiopathology / Q000517:prevention & control
D010567:Pertussis Vaccine